Pulmonary Lymphoepithelioma-like Carcinoma

Area of Science:

• Oncology
• Pathology
• Virology

Background:

• Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare subtype of non-small cell lung cancer (NSCLC).
• It predominantly affects young, non-smoking Asian individuals.
• LELC presents at an earlier stage and shows a better prognosis compared to other NSCLC types.

Purpose of the Study:

• To describe the key histological and etiological features of pulmonary lymphoepithelioma-like carcinoma.
• To highlight diagnostic criteria and differential diagnoses.
• To discuss the molecular characteristics, including viral association and common genetic alterations.

Main Methods:

• Histopathological examination of tumor morphology.
• Immunohistochemical analysis for cellular infiltrates.
• Epstein-Barr virus (EBV) detection in tumor cells.
• Analysis of EGFR mutations and ALK rearrangements.
• Assessment of programmed death ligand-1 (PD-L1) expression.

Main Results:

• Tumor morphology mimics nasopharyngeal undifferentiated carcinoma with syncytial tumor cells and a dense lymphocytic infiltrate.
• Epstein-Barr virus presence is a critical diagnostic marker.
• EGFR mutations and ALK rearrangements are infrequent.
• High programmed death ligand-1 expression is observed in most cases.

Conclusions:

• Pulmonary LELC is a distinct NSCLC entity with unique demographic, histological, and etiological features.
• EBV infection is central to its pathogenesis.
• The absence of common driver mutations and frequent PD-L1 expression suggest potential therapeutic avenues.